Atypical Hemolytic Uremic Syndrome and Chronic Ulcerative Colitis Treated with Eculizumab
Tennille N. Webb, Heidi Griffiths, Yosuke Miyashita, Riha Bhatt, Ronald Jaffe, Michael Moritz, Johannes Hofer, Agnieszka Swiatecka-Urban
International Journal of Medical and Pharmaceutical Case Reports · pp. 105–112 · Published 19 Jun 2015
10.9734/IJMPCR/2015/18771Abstract
Background: Hemolytic-uremic syndrome (HUS) presents with hemolytic anemia, thrombo-cytopenia, and thrombotic microangiopathy of the kidney and usually results from Shiga-toxin induced activation of the alternative complement pathway. Gastroenteritis is a common feature of the Shiga-toxin producing Escherichia coli HUS, referred to as STEC-HUS. An inherited or acquired complement dysregulation may lead to HUS referred to as non-STEC or atypical (a)HUS. Although gastroenteritis is not a common presentation of aHUS, some patients develop ischemic colitis and may be misdiagnosed as acute appendicitis or acute ulcerative colitis (UC). Case Diagnosis –Treatment: We present a patient with low circulating complement (C) 3 levels who developed aHUS in the course of chronic active UC. Resolution of renal and gastrointestinal manifestations in response to treatment with eculizumab, a humanized monoclonal antibody against terminal C5 protein suggests the role of alternative complement in the pathogenesis of both, aHUS and UC. Conclusion: This case illustrates that dysregulation of the alternative complement pathway may manifest in other organs besides the kidney and that the circulating C3 levels do not correlate with the disease activity or the clinical response to eculizumab.
Cited by 14
Yeboah EK, Thida AM, Moradi R · Cureus · 2025
Hendrickx T, Peetermans M, D'Hoore A · Acta Gastroenterol Belg · 2024
Yerigeri K, Kadatane S, Mongan K · J Multidiscip Healthc · 2023
Ozer H, Baloglu İ, Turkmen K · Gastroenterol Hepatol Bed Bench · 2023
Raina R, Vijayvargiya N, Khooblall A · Cells · 2021
Horváth O, Kelen K, Prohászka Z · Pediatr Nephrol · 2021
Koopman JJE, van Essen MF, Rennke HG · Front Immunol · 2020
Hanna RM, Merin N, Burwick RM · Thromb J · 2019
Shin HS, Nester CM, Dixon BP. · Clin Nephrol Case Stud · 2019
Viada Bris JF, Velasco Rodríguez-Belvís M, de Lucas Collantes C · Inflamm Bowel Dis · 2019
Related research
- The Influence of Risk Factors on Acute Kidney Injury in Rhabdomyolysis Patients: A Comprehensive Review — shares topic coverage
- Feasibility and Hemodynamic Tolerability of Sustained Low- Efficiency Dialysis in Critically Ill Patients with Acute Kidney Injury — shares topic coverage
- Spectrum and Outcomes in Patients with Skin and Subcutaneous Tissue Infections and Severe Renal Dysfunction — shares topic coverage
- Evaluation of Kidney Injury Molecule-1, Creatinine and Urea Levels in Alcohol, Cigarettes, and Polyherbal Medicines (Agbo) Consumers in Nnewi Metropolis, Nigeria — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
14
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.